"Sinus passages can become inflamed from an infection or allergies leading to the trapping air, fluid, and mucus inside — this creates pressure that leads to pain in the forehead, cheeks ...

Clinical trials have shown the treatment to be particularly beneficial in for those whose symptoms cannot be managed by standard treatments, such as steroid nasal sprays and antihistamines. By giving ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

Please provide your email address to receive an email when new articles are posted on . The FDA has advised health care professionals that they should not use unapproved epinephrine nasal ...